Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $44.0400 (3.45%) ($42.7800 - $44.0400) on Thu. Aug. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.18% (three month average) | RSI | 55 | Latest Price | $44.0400(3.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(39%) BNDX(29%) IBB(29%) IGOV(24%) IFRA(21%) | Factors Impacting HALO price | HALO will decline at least -1.09% in a week (0% probabilities). INDA(-30%) TBT(-19%) EWY(-18%) SKYY(-17%) IPO(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.09% (StdDev 2.18%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $42.88(2.71%) | 10 Day Moving Average | $42.84(2.8%) | 20 Day Moving Average | $42.5(3.62%) | To recent high | 0% | To recent low | 35.8% | Market Cap | $6.019b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |